Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show, Webcast

2seventy bio to Present at the 5th Annual Cowen IO Next Summit

2seventy bio, Inc. (Nasdaq: TSVT) announced today that it will participate in a fireside chat at the 5th Annual Cowen IO Next Summit on November 15, at 1:15pm ET.

A webcast of the presentation will be available via the investor relations section of the 2seventy bio website for 30 days following the event.

About 2seventy bio

Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away and our goal is to work at the maximum speed of translating human thought into action ? 270 miles per hour ? to give the people we serve more time. We are building the leading immuno-oncology cell therapy company, focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. With a deep understanding of the human body's immune response to tumor cells and how to translate cell therapies into practice, we're applying this knowledge to deliver next generation cellular therapies that focus on a broad range of hematologic malignancies, including the first FDA-approved CAR T cell therapy for multiple myeloma, as well as solid tumors. Our research and development is focused on delivering therapies that are designed with the goal to "think" smarter and faster than the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our "why" and keeping our people and culture top of mind every day.

For more information, visit www.2seventybio.com.

Follow 2seventy bio on social media: Twitter and LinkedIn.

2seventy bio is a trademark of 2seventy bio, Inc.

These press releases may also interest you

at 03:35
Celmatix Inc. a biotechnology company focused on ovarian biology, today announced the identification of a novel AMHR2 agonist compound that has demonstrated robust biological activity in multiple therapeutically relevant preclinical assays and a...

at 03:09
Novo Holdings A/S, a leading international life sciences investor, today announces that its portfolio company F2G Ltd....

at 03:00
ProductLife Group (PLG), a global provider of Regulatory & Compliance consulting and outsourcing services, announced on May 12, 2022, that it had acquired Quoretex, a life sciences...

at 03:00
Sedentary lifestyles, missed medical appointments and the broader health impact of the COVID-19 pandemic may take the UK years to recover from. That's according to the new Bupa Wellbeing Index, a landmark survey conducted amongst 8,000 UK adults that...

at 03:00
the German life science biotech firm, LenioBio GmbH, today announced the generation of a novel plant glycan knockout cell line that will increase the versatility and flexibility of the company's cell-free protein synthesis (CFPS) system, ALiCE®....

at 03:00
SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic...

News published on 10 november 2021 at 16:35 and distributed by: